Model, restaurateur and lifestyle icon Barbara Elaine Smith, known most commonly as B. Smith, died Saturday at age 70 after a seven year fight with Alzheimer’s disease.
The Latest Alzheimer’s Disease Research and Social Media Posts
“Alzheimer’s disease (Alzheimer’s), an ultimately fatal form of dementia, is the sixth leading cause of death in the United States, accounting for 3.6% of all deaths in 2014.” – Centers for Disease Control and Prevention
Women in their late 50s and early 60s who eat at least two servings of walnuts per week had an increased likelihood of healthy aging compared to those who did not.
Transcranial magnetic stimulation (TMS) shows promise in diminishing the effects of early dementia and proves a safe and effective method for treating acute migraine and PPA.
After decades of effort and untold millions invested in the search for an effective treatment for Alzheimer’s, the disease remains unchecked and rampant. Most recently, the New York Times reported that researchers declared defeat after the failure of yet another experimental drug designed to fight the formation of the disease’s signature amyloid plaque in the brain.
A Phase 2 clinical trial testing Annovis Bio’s oral therapy ANV401 (also known as Posiphen) in people with early Alzheimer’s disease can continue without changes, according to a positive review by the study’s independent Data Safety Monitoring Board (DSMB).
Using a mini-brain model, researchers report the popular SSRI antidepressant Paroxetine can induce brain cell developmental abnormalities that could lead to adverse effects in children.
Solanezumab and Gantenerumab Fail to Slow Memory Loss or Cognitive Decline in Early-onset Alzheimer’s, Study Finds
Two investigational treatments, solanezumab and gantenerumab, failed to prevent memory loss or cognitive decline in patients with a rare, inherited form of early-onset Alzheimer’s disease, who were enrolled in a Phase 2/3 clinical trial (NCT01760005).
Dementia—it’s one of the most dreaded diseases of our time. About 5.8 million people are currently living with Alzheimer’s disease, the most common form of dementia. And that number is expected to skyrocket to 14 million by 2050.
For the first time, an intervention – lifting weights – has been able to slow and even halt degeneration, over a long period, in brain areas particularly vulnerable to Alzheimer’s disease.